Status:
RECRUITING
High-dose Dual Therapy and Minocycline-cotaining Quadruple Therapy for Helicobacter Pylori Infection
Lead Sponsor:
Shanghai Jiao Tong University School of Medicine
Conditions:
Helicobacter Pylori Infection
Eligibility:
All Genders
18-70 years
Phase:
PHASE4
Brief Summary
This study is a multicentra, prospective study. The enrolled patients are HP positive. They are diagnosed as HP positive by rapid urease test and/or 13C urea breath test. According to the declaration ...
Eligibility Criteria
Inclusion
- Ability and willingness to participate in the study and to sign and give informed consent
- Confirmed H. pylori infection
Exclusion
- Pregnant and lactating women;
- History of gastrointestinal malignancies;
- History of previous subtotal gastrectomy;
- Serious dysfunction of heart, liver, kidney, lung and other important organs and congenital diseases; Such as grade IV cardiac insufficiency, liver failure, uremia, respiratory failure, hemophilia, Wilson disease, etc;
- History of hematological diseases
- People who are allergic to drugs;
- The guardian or patient refused to join the group;
- Alcohol and / or drug abuse (addiction or dependence) or poor compliance judged by doctors;
- No legal capacity or poor self-knowledge
- administration of antibiotics, bismuth, antisecretory drugs, or Chinese herb medicine in the preceding 8 weeks
Key Trial Info
Start Date :
August 21 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 30 2026
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT06561698
Start Date
August 21 2024
End Date
August 30 2026
Last Update
December 30 2024
Active Locations (10)
Enter a location and click search to find clinical trials sorted by distance.
1
Hebi People's Hospital
Hebi, Henan, China
2
Jiaozuo People's Hospital
Jiaozuo, Henan, China
3
Luoyang central Hospital
Luoyang, Henan, China
4
The first people's hospital of ping ding shan
Pingdingshan, Henan, China